A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 922 participants.
Also called NCT07146048
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 922 participants
- Registry
-
NCT07146048
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Uganda
- Registry status
- Recruiting
Technical summary
Registry record NCT07146048. Randomized; single masking; primary purpose treatment. Start 2026-03-23 (actual); primary completion 2029-02-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop
- Acronym
- GOAL-Stop
- Condition
- Rheumatic Heart Disease
- Intervention (Drug)
- Secondary Prophylaxis
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Collaborator
- Uganda Heart Institute
- Collaborator
- Coefficient Giving
- Collaborator
- Thrasher Research Fund
Record details
- Record id
cardio:ct-nct07146048- Content hash
e25968df613a467f07ed4499cae1bcd5c6f3d685434929c7956d5a537ee3ed69